Test Price
2,800 AED✅ Home Collection Available
MIR17HG Gene (Feingold Syndrome Type 2) Next‑Generation Sequencing (Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MIR17HG لمتلازمة فاينغولد النوع الثاني بتقنية التسلسل الجيني الشامل (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Diagnostic Certainty, Delivered with UAE Precision
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited NGS processing with 100× coverage and clinical‑grade bioinformatics (Cert: INT/EGQ/2509DA/3139).
- Hospital‑Grade Cold‑Chain Home Collection (8 AM – 11 PM) – VIP mobile phlebotomy, preserving DNA integrity from your doorstep to our Dubai laboratory.
- Post‑Test Clinical Guidance – Complimentary tele‑counselling with a DHA‑licensed genetic specialist to interpret results.
- Direct Insurance Billing Verification – WhatsApp +971 54 548 8731 for instant pre‑authorization and DHA‑compliant invoicing.
ضمان تشخيصي بنسبة 99.9% من خلال تحليل معتمد وفق الآيزو، مع دعم استشاري سريري فوري بعد ظهور النتائج.
Comprehensive Gene Analysis for Definitive Diagnosis
The MIR17HG (Feingold Syndrome Type 2) NGS test identifies pathogenic germline variants in the MIR17HG gene, confirming a rare genetic syndrome characterized by microcephaly, digital anomalies, and potential systemic involvement. This test uses high‑depth next‑generation sequencing to detect single nucleotide variants (SNVs), insertions/deletions (indels), and copy number variations (CNVs) with unmatched precision.
يوفر هذا الفحص الجيني الشامل تأكيدًا تشخيصيًا دقيقًا لمتلازمة فاينغولد النوع الثاني، مع تغطية تحليلية واسعة تشمل جميع أنواع الطفرات.
| Feature | Our NGS Test | Closest Alternative |
|---|---|---|
| Accuracy | ≥99.9% for SNVs, indels & CNVs | Sanger sequencing (misses CNVs) |
| Method | NGS with clinically validated bioinformatics | Sanger or exome with limited CNV calling |
| Turnaround Time | 3–4 weeks | 4–8 weeks (exome/external referral) |
| Price | 2800 AED (insurance covered) | 3000–4500 AED (limited coverage) |
Physician Insight & Safety Protocol
“As a clinician, I recognise the profound anxiety a possible genetic diagnosis brings to your family. This MIR17HG NGS test provides the definitive molecular answers you need to plan future healthcare with confidence. Please remember to correlate these findings with a comprehensive clinical evaluation by your consulting specialist.”
— Dr. Prabhakar Reddy, DHA License No. 61713011
⚠️ Medication Warning:
Do not discontinue or adjust any prescribed medication without consulting your treating physician. This genetic test does not provide immediate therapeutic guidance and must be integrated into your overall care plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Test cannot proceed without prior genetic counselling and signed informed consent (mandatory per UAE CDS Law). Not suitable for standalone screening in asymptomatic individuals without a positive family history or clinical suspicion.
- Emergency Red Flags: If you or your child develop acute neurological deterioration, uncontrolled seizures, severe respiratory distress, or signs of shock, seek immediate emergency medical care. Do not wait for genetic test results.
- Minors: In compliance with UAE CDS Law 2026, testing of minors requires legal guardian consent and genetic counselling adapted to paediatric protocols.
Frequently Asked Questions
1. What is the MIR17HG gene test used for?
Direct Answer: The MIR17HG NGS test confirms Feingold Syndrome Type 2 by analyzing genetic mutations with precision.
يؤكد فحص MIR17HG بتقنية التسلسل الجيني الشامل تشخيص متلازمة فاينغولد النوع الثاني عبر تحليل الطفرات الجينية بدقة عالية.
2. How is the test performed?
Direct Answer: A blood or DNA sample is collected, and NGS technology sequences the MIR17HG gene with high-depth coverage.
يتم جمع عينة دم أو حمض نووي، ثم تقوم تقنية التسلسل الجيني الشامل بقراءة جين MIR17HG بتغطية عميقة ودقة عالية.
3. What is the turnaround time and cost?
Direct Answer: Results are delivered within 3–4 weeks at a cost of 2800 AED with insurance options.
تظهر النتائج خلال 3 إلى 4 أسابيع بتكلفة 2800 درهم إماراتي مع إمكانية تغطية تأمينية مباشرة.
This test is conducted under UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), adhering to DHA/MOHAP standards, UAE PDPL data privacy, and ISO 15189:2022 quality requirements. Laboratory Facility License: 9834453. All personal health data is managed in compliance with the UAE Personal Data Protection Law.
Pre‑ requirements: A genetic counselling session (including pedigree chart) is mandatory before sample collection. The sample type can be whole blood, extracted DNA, or one drop of blood on an FTA card. Results interpretation must be done by a qualified clinician.
For immediate assistance, WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians